Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
The Journal of Infectious Diseases|December 2, 2025
Improved immune response against influenza A viruses with receipt of a recombinant influenza vaccine in healthcare personnel with prior low antibody response to egg-based influenza vaccines, Israel, 2019-20Kelsey M Sumner, Mark Katz, Avital Hirsch, et al.
Nature Communications|January 4, 2024
Redirecting antibody responses from egg-adapted epitopes following repeat vaccination with recombinant or cell culture-based versus egg-based influenza vaccinesFeng Liu, F Liaini Gross, Sneha Joshi, et al.
Vaccine|May 11, 2020
Intent to obtain pediatric influenza vaccine among mothers in four middle income countriesAbram L Wagner, Aubree Gordon, Veronica L Tallo, et al.
Open Forum Infectious Diseases|June 12, 2023
Immunogenicity of High-Dose Egg-Based, Recombinant, and Cell Culture-Based Influenza Vaccines Compared With Standard-Dose Egg-Based Influenza Vaccine Among Health Care Personnel Aged 18-65 Years in 2019-2020Allison L Naleway, Sara S Kim, Brendan Flannery, et al.
Pediatrics|August 16, 2022
Test-to-Stay After SARS-CoV-2 Exposure: A Mitigation Strategy for Optionally Masked K-12 SchoolsMelissa M Campbell, Daniel K Benjamin, Tara K Mann, et al.
Nature Immunology|May 27, 2025
Intrinsic immunogenicity is a major determinant of type-specific responses in SARS-CoV-2 infectionsGrace E Quirk, Marta V Schoenle, Kameron L Peyton, et al.
JAMA Network Open|February 24, 2025
COVID-19 Vaccination and Odds of Post-COVID-19 Condition Symptoms in Children Aged 5 to 17 YearsAnna R Yousaf, Josephine Mak, Lisa Gwynn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2021
Neutralizing Antibody Response to Pseudotype Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Differs Between mRNA-1273 and BNT162b2 Coronavirus Disease 2019 (COVID-19) Vaccines and by History of SARS-CoV-2 InfectionHarmony L Tyner, Jefferey L Burgess, Lauren Grant, et al.
MMWR. Morbidity and Mortality Weekly Report|December 30, 2021
Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12-17 Years - Arizona, July-December 2021Karen Lutrick, Patrick Rivers, Young M Yoo, et al.
The Journal of Infectious Diseases|November 12, 2024
Association of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination and Reductions in Post COVID Conditions Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection in a US Prospective Cohort of Essential WorkersJosephine Mak, Sana Khan, Amadea Britton, et al.
Pageof 4